Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 12/20 | 0.70 |
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | NAAA | Q02083 | 2/20 | 0.57 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.57 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.57 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2442650 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL9960369 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL19468468 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL2441345 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL2440729 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL19468472 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL19468470 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL19468496 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL378195 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 | |
| SCHEMBL1694195 | 1.00 | EPHX1 (0.70) | EPHX1CASP2NAAAZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240059926-A1 | COATING COMPOSITION COMPRISING A CARBAMATE-FUNCTIONAL POLY(ETHYLENE-ACRYLATE) COPOLYMER AND METHOD OF COATING SUBSTRATES | BASF COATINGS GMBH (DE) | 2024-02-22 | — | — | US | claimed |
| EP-2841496-B1 | RUBBER COMPOSITIONS | ALLNEX GERMANY GMBH (DE) | 2022-10-26 | — | — | EP | claimed |
| WO-2022148584-A1 | COATING COMPOSITION COMPRISING A CARBAMATE-FUNCTIONAL POLY(ETHYLENE-ACRYLATE) COPOLYMER AND METHOD OF COATING SUBSTRATES | BASF COATINGS GMBH (DE) | 2022-07-14 | — | — | WO | claimed |
| CN-112831008-B | Styrene butadiene rubber liquid crystal elastomer with self-repairing and welding functions and preparation method thereof | 大连理工大学 | 2022-06-21 | — | — | CN | claimed |
| EP-3577149-B1 | METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-02-09 | — | — | EP | claimed |
| EP-3500611-B1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2021-08-11 | — | — | EP | claimed |
| EP-3256508-B1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-27 | — | — | EP | claimed |
| EP-3140341-B1 | METHOD USING ZIRCONIUM CATALYST FOR PRODUCING CARBAMATE-FUNCTIONAL MATERIALS | BASF COATINGS GMBH (DE) | 2018-08-29 | — | — | EP | claimed |
| US-10059789-B2 | Method using titanium catalyst for producing carbamate-functional materials | BASF COATINGS GMBH (DE) | 2018-08-28 | — | — | US | claimed |
| EP-2413697-B1 | STABILISATION OF COMPOUNDS CONTAINING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2017-11-08 | — | — | EP | claimed |
| EP-0550879-B1 | Process for coating cellulosic membranes | AKZO NOBEL NV (NL) | 1997-03-12 | — | — | EP | claimed |
| US-5580982-A | ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS | HOECHST MARION ROUSSEL INC. (US) | 1996-12-03 | — | — | US | claimed |
| JP-H08506094-A | — | — | 1996-07-02 | — | — | JP | claimed |
| US-5494908-A | ANTIDEPRESSANT | HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) | 1996-02-27 | — | — | US | claimed |
| EP-0669920-A4 | SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS. | HOECHST ROUSSEL PHARMA (US) | 1995-10-25 | — | — | EP | claimed |
| EP-0669920-A1 | SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS | HOECHST MARION ROUSSEL, Inc. (US) | 1995-09-06 | — | — | EP | claimed |
| EP-0648771-A1 | Galanthamine derivatives, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1995-04-19 | — | — | EP | claimed |
| US-5360636-A | Method for coating cellulosic membranes | AKZO NV (NL) | 1994-11-01 | — | — | US | claimed |
| WO-1994012495-A1 | SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1994-06-09 | — | — | WO | claimed |
| EP-0285650-B1 | SOLVENT BORNE HIGH SOLIDS COATING COMPOSITIONS | UNION CARBIDE CORPORATION (US) | 1992-10-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10059789-B2 | Method using titanium catalyst for producing carbamate-functional materials | CTSH, CTSF, CAT | EPHX1 2085/4885CASP2 1085/4885NAAA 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.